Warfarin loading

Challenges in Haemostasis & thrombosis
British Society for Haemostasis & Thrombosis
7th October 2010
British Library, London
Registration form available at http://www.bsht.org.uk/ or from Conference Organiser,
Jean Machin, at mach263@msn.com
08.30 - 09.20
REGISTRATION, EXHIBITION & coffee & tea
09.20 - 09.30
Welcome & BSHT update
Dr Trevor Baglin
Chairpersons Dr Jim Crawley & Dr Sue Pavord
09.30- 10.00
Hospital-acquired thrombosis
Dr Ander Cohen
- what is the extent of the problem? -is the risk overestimated? - where do we want to get to and how do we get there? 10.00 - 10.30
Understanding flow based haemostasis: the VWF and ADAMTS13 axis
Professor David Lane
- how does ADAMTS13 function as a protease? - what do VWF and ADAMTS13 like about each other? 10.30 - 10.50
NIHR Comprehensive Clinical Research Network
Dr Peter Collins
10.50 -11.20
EXHIBITION & coffee & tea
11.20 - 12.00
Von Willebrands Disease
Dr David Keeling & Dr Anne Goodeve
- is it necessary to classify type 2 VWD? - is a formalised bleeding score useful? 2) Unravelling the genotype-phenotype relationship of Von Willebrand Disease - what have we learnt from genotyping studies? - how should we think about the VWD subtypes from a genetic perspective? - what are we likely to learn in the future? 12.00 - 12.40
Haemophilia A & B
Dr Peter Collins
- what should we do for adults with established inhibitors? 12.40 - 14.00
EXHIBITION, lunch and AGM (12.40 to 13.10)
Chairpersons Dr Paul Harrison & Dr Henry Watson
14.00 - 14.45
Platelet function for the 'non-platelet specialist'
Professor Hans Deckmyn
14.45 - 15.30
Thrombin Generation: what have we learnt so far?
Professor Coen Hemker
15.30 - 16.00
EXHIBITION & coffee & tea
16.00 - 16.30
PROPOSAL AND ROUND TABLE DISCUSSION: A plasma free blood
transfusion service: should all plasma be replaced with factor
concentrates?
- introduction - Trevor Baglin
- the national comparative audit Shubha Allard
- what effect does FFP administration have on clotting tests? Dora Foukanelli
- is the coagulopathy of critical illness a bleeding disorder? Trevor Baglin
Round table discussion with invited experts 16.30- 16.55
Treating acquired coagulopathy with antifibrinolytics: aprotonin and
tranexamic acid
Professor Beverley Hunt
- when should tranexamic acid be prescribed? 16.55 - 17.00
Conclusions and close of meeting
Dr Trevor Baglin
17.00 – 18.00 Drinks reception

Source: http://b-s-h.org.uk/documents/2010728165855Challenges_meeting_London_2010.pdf